Xiuling Li

发表

Identification of the epitope in human poliovirus type 1 Sabin strain recognized by the monoclonal antibody 1G10 using mimotope strategy.

Zhongyang Zhang, Weiwei Lu, H. Bai, 2019, Journal of virological methods.

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial

Jing-xin Li, F. Zhu, H. Guo, 2014, Human vaccines & immunotherapeutics.

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Xing Wu, K. Chu, F. Li, 2013, The Lancet.

A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus

Zhongyang Zhang, Weiwei Lu, H. Bai, 2017, Journal of medical virology.

Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2

Jianping Ding, Hongzhou Lu, Lu Lu, 2022, Nature Microbiology.

Novel neutralization mechanism of a human antibody with pan-coronavirus reactivity

Hongzhou Lu, Lu Lu, R. Yan, 2021 .

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

Yixiao Lin, Hongzhou Lu, Jianqing Xu, 2021, Genome medicine.

Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice

Shiwen Wang, De-xin Li, Chuan Li, 2022, Biosafety and Health.

Identification of a candidate standard strain of severe fever with thrombocytopenia syndrome virus for vaccine quality control in China using a cross-neutralization assay.

Junzhi Wang, M. Liang, Xiuling Li, 2017, Biologicals : journal of the International Association of Biological Standardization.

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

Xing Wu, T. Cheng, Zhenglun Liang, 2021, Human vaccines & immunotherapeutics.

AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses

Xiuling Li, Jian Luo, Xueying Liu, 2022, Vaccines.

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial

Yan Liu, X. Guan, Y. Tong, 2022, EClinicalMedicine.

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study

K. Chu, Zhenglun Liang, Jing-xin Li, 2017, The Journal of infectious diseases.

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.

Junzhi Wang, Zhenglun Liang, F. Li, 2011, Vaccine.

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

De-xin Li, Chuan Li, M. Liang, 2014, Virology Journal.

Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012‐2013

Zhenglun Liang, Jing-xin Li, F. Zhu, 2015, Journal of medical virology.

Comparison of the neutralizing activities of antibodies in clinical sera against both Sabin and wild-type polio pseudoviruses

Zhongyang Zhang, Shaohua Liu, Xiuling Li, 2021, Journal of Virological Methods.

Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children

K. Chu, Jing-xin Li, F. Zhu, 2012, Human vaccines & immunotherapeutics.

Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013–2014

Zhenglun Liang, Jing-xin Li, F. Zhu, 2017, Human vaccines & immunotherapeutics.

A Short 5′triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-I

Xing Wu, Zhenglun Liang, Xiuling Li, 2022, Viruses.

Molecular Determinants of Enterovirus 71 Viral Entry

Wenhui Li, Zhenglun Liang, Xinliang Shen, 2012, The Journal of Biological Chemistry.

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Pei Liu, Fan Gao, Kai Chu, 2013, The Lancet.

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial

F. Zhu, Xiuling Li, Pei Liu, 2022, Human vaccines & immunotherapeutics.

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo

Xing Wu, Zhenglun Liang, Xiuling Li, 2018, Human vaccines & immunotherapeutics.

Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants

K. Chu, Jing-xin Li, F. Zhu, 2012, The Pediatric infectious disease journal.

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of SFTS vaccines.

Junzhi Wang, Lei Chen, Xiuling Li, 2019, Biologicals : journal of the International Association of Biological Standardization.

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice

Zhenglun Liang, Xinliang Shen, Xiuling Li, 2012, PloS one.

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides.

Y. Yi, Shengli Bi, Xinliang Shen, 2009, Biochemical and biophysical research communications.

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants

Min Zhang, Xiuling Li, Jian Luo, 2023, Human Vaccines & Immunotherapeutics.

Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice

Xiuling Li, Jian Luo, Xu Zhou, 2023, Virology Journal.

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

De-xin Li, Chuan Li, M. Liang, 2014, Virology Journal.